Loading clinical trials...
Loading clinical trials...
This is a continuation of our previous studies on Progressive Multifocal Leukoencephalopathy (PML). We will focus on the role of inflammation in PML, and define prognostic markers of disease evolution...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Beth Israel Deaconess Medical Center
Collaborators
NCT04453917 · Progressive Multifocal Leukoencephalopathy
NCT04781309 · Progressive Multifocal Leukoencephalopathy
NCT03399981 · Progressive Multifocal Leukoencephalopathy
NCT04091932 · Progressive Multifocal Leukoencephalopathy, AIDS
NCT02004444 · Progressive Multifocal Leukoencephalopathy, Multiple Sclerosis
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions